
EID Parry India Announces Audited Financial Results for Quarter and Year Ended March 31, 2026
EID Parry India Limited announced the approval of its audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2026. The Board of Directors held its meeting on May 26, 2026, to consider and approve the results.The company also announced that its 51st Annual General Meeting (AGM) of the Members is scheduled for Wednesday, August 12, 2026, to be held through Video Conferencing (VC) / Other Audio-Visual Means (OAVM).
Financial Results Overview
The audited Standalone and Consolidated Financial Results provide a detailed look at the company's performance across various segments.Standalone Financial Results (Rs. in Lakhs)
| Particulars | Quarter Ended March 31, 2026 | Quarter Ended December 31, 2025 | Quarter Ended March 31, 2025 | Year Ended March 31, 2026 | Year Ended March 31, 2025 |
|---|---|---|---|---|---|
| Total Income | 1,01,729 | 79,726 | 95,026 | 3,56,847 | 3,45,700 |
| Total Expenses | 83,908 | 87,060 | 78,967 | 3,42,442 | 3,44,944 |
| Loss after tax (before OCI) | (34,039) | (5,435) | (23,170) | (70,828) | (42,830) |
| Total comprehensive income | (33,883) | (5,433) | (23,114) | (67,233) | (39,271) |
| Total Assets | 4,41,842 | 3,85,651 | 4,40,746 | 4,41,842 | 4,40,746 |
| Total Equity and Liabilities | 4,41,842 | 1,64,449 | 1,86,770 | 2,54,558 | 1,86,770 |
Consolidated Financial Results (Rs. in Lakhs)
| Particulars | Quarter Ended March 31, 2026 | Quarter Ended December 31, 2025 | Quarter Ended March 31, 2025 | Year Ended March 31, 2026 | Year Ended March 31, 2025 |
|---|---|---|---|---|---|
| Total Income | 7,93,117 | 10,37,173 | 6,92,356 | 38,88,344 | 31,96,779 |
| Total Expenses | 7,61,511 | 9,78,380 | 6,51,920 | 36,30,159 | 29,80,624 |
| Loss after tax (before OCI) | (28,717) | 43,700 | 53,944 | 1,38,045 | 1,77,254 |
| Total comprehensive income | (34,209) | 52,141 | 48,840 | 13,48,42 | 1,56,808 |
(Note: The standalone and consolidated results provide comprehensive details on revenues, expenses, and comprehensive income for the reporting periods.)
Segment Performance Analysis
The company operates across several segments, including Sugar, Co-generation, Distillery, Nutraceuticals, and Consumer Products.Segment Revenue from Operations (Rs. in Lakhs)
| Segment | March 31, 2026 | December 31, 2025 | March 31, 2025 | March 31, 2026 | March 31, 2025 |
|---|---|---|---|---|---|
| Nutrient and allied business | 4,95,250 | 7,76,177 | 4,32,096 | 27,72,687 | 21,65,228 |
| Crop protection | 1,07,623 | 1,09,829 | 69,872 | 39,682 | 2,63,705 |
| Sugar | 1,47,264 | 1,10,32 | 1,37,289 | 5,36,568 | 5,77,891 |
| Co-generation | 6,562 | 3,659 | 5,793 | 12,168 | 12,565 |
| Distillery | 27,469 | 28,905 | 26,819 | 1,15,137 | 1,10,181 |
| Nutraceuticals | 4.951 | 6,191 | 5.931 | 19,963 | 19.754 |
| Consumer products | 11,484 | 13,965 | 19,532 | 60,715 | 88,389 |
Segment Profit/Loss Before Tax and Interest (Rs. in Lakhs)
| Segment | March 31, 2026 | December 31, 2025 | March 31, 2025 | March 31, 2026 | March 31, 2025 |
|---|---|---|---|---|---|
| Nutrient and allied business | 24.444 | 60.656 | 29.733 | 2,46,386 | 2,20,577 |
| Crop protection | 12,029 | 13.420 | 10.111 | 51.081 | 36.328 |
| Sugar | 7.004 | (1,781) | 322 | 5.409 | (11,521) |
| Co-generation | (485) | 234 | 287 | (4,677) | (5,839) |
| Distillery | 180 | (1.479) | 1,953 | (1,379) | 3,687 |
| Nutraceuticals | 766 | (158) | 1.097 | 1,873 | 251 |
| Consumer products | (3,265) | (3,147) | (1,253) | (10,852) | (5,826) |
Strategic Updates and Corporate Actions
Closure of PSRIPL OperationsThe Board of Directors of EID Parry India Limited and its wholly owned subsidiary, Parry Sugars Refinery India Private Limited (PSRIPL), approved the closure of operations of PSRIPL's sugar refinery unit, effective March 31, 2026. The subsidiary had been assessed as unviable due to adverse impacts from global market conditions, higher operating costs, and operational disruptions.
Key Provisions and Charges
During the financial year ended March 31, 2026, impairment losses were recognized in the following areas:
- Impairment of investment in subsidiary: ₹40,060 lakhs for the year ended March 31, 2026.
- Closure related obligations and restructuring cost: ₹27,013 lakhs for the year ended March 31, 2026.
- Impairment of property plant and equipment: ₹13,769 lakhs for the year ended March 31, 2026.
Acquisitions and Investments
The Consolidated Financial Results include results from the acquisition of NACL Limited by Coromandel International Limited (CIL), a subsidiary of the Company, on March 12, 2025. CIL acquired an aggregate of 1,06,912,581 equity shares of NACL, representing 53.08% of the voting share capital. The transaction resulted in a goodwill of ₹38,615 lakhs.
Future Outlook and Advisory Details
The Company noted that the figures for the current and previous quarters are not comparable due to the seasonal nature of the business.The company reaffirmed its commitment to its core businesses, including Sugar and Nutraceuticals, and is undergoing a transformation from a sugar enterprise into a comprehensive Food, Nutrition, and Bioenergy establishment. In the Nutraceuticals segment, the focus includes management restructuring of the U.S. subsidiary and expanding into new product segments like Derma/Hair Health.
***
Disclaimer: This report is based solely on the financial figures and operational details provided in the source material and does not constitute professional investment advice.
EIDPARRY Stock Price Movement
Shares of EID Parry India Limited are shedding 1.89% in live trading as of 3:07 PM, currently trading at ₹774.95 after dropping ₹14.90. The equity has seen significant intraday interest, moving on a total traded volume of 620,669 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.